1. Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, et al. Anti-human leukocyte antigen and donor-specific antibodies detected by lumine posttransplant serve as biomarkers for chronic rejec- tion of renal allografts. Transplantation 2009; 87(10): 1505–1513. https://doi.org/10.1097/TP.0b013e3181a44206 PMID: 19461487
2. O’Leary JG, Kaneku H, Susskind BM, Jennings LW, Neri MA, Davis GL, et al. High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant. 2011; 11(9): 1868–1876. https://doi.org/10.1111/j.1600-6143.2011.03593.x PMID: 21672151
3. Kaneku H, O’Leary JG, Taniguchi M, Susskind BM, Terasaki PI, Klinmalm GB. Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation. Liver Transpl. 2012; 18(8): 984–992. https://doi.org/10.1002/lt. 23451 PMID: 22508525
4. Otten HG, Verhaar MC, Borst HP, van Eck M, van Ginkel WG, Hene RJ, et al. The significance of pre- transplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation. Clin Exp Immunol. 2013; 173(3): 536–543. https://doi.org/10.1111/cei.12127 PMID: 23627692
5. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol. 2005; 5(10): 807– 817. https://doi.org/10.1038/nri1702 PMID: 16175181
6. Sicard A, Phares TW, Yu H, Fan R, Baldwin WM 3rd, Fairchild RL, et al. The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients. Am J Transplant. 2012; 12(7): 1708–1719. https://doi.org/10.1111/j.1600-6143.2012.04009.x PMID: 22420367
7. Villaudy J, Schotte R, Legrand N, Spits H. Critical assessment of human antibody generation in human- ized mouse models. J Immunol Methods 2014; 410: 18–27. https://doi.org/10.1016/j.jim.2014.06.010 PMID: 24952244
8. Hogenes M, Huibers M, Kroone C, de Weger R. Humanized mouse models in transplantation research. Transplant Rev (Orlando). 2014; 28(3): 103–110. https://doi.org/10.1016/j.trre.2014.02.002 PMID: 24636846
9. Nakauchi Y, Yamazaki S, Napier SC, Usui J, Ota Y, Takahashi S, et al. Effective treatment against severe graft-versus-host disease with allele-specific anti-HLA monoclonal antibody in a humanized mouse model. Exp Hematol. 2015; 43(2): 79–88. https://doi.org/10.1016/j.exphem.2014.10.008 PMID: 25448490
10. Kenney LL, Shultz LD, Greiner DL, Brehm MA. Humanized mouse models for transplant immunology. Am J Transplant. 2016; 16(2): 389–397. https://doi.org/10.1111/ajt.13520 PMID: 26588186
11. Theocharides AP, Rongvaux A, Fritsch K, Flavell RA, Manz MG. Humanized hemato-lymphoid system mice. Haematologica. 2016; 101(1): 5–19. https://doi.org/10.3324/haematol.2014.115212 PMID: 26721800
12. Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson KC. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood. 1995; 85(7):1903–12. PMID: 7535594
13. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013; 48(3): 452–458. https://doi.org/10.1038/bmt.2012.244 PMID: 23208313
14. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 1988; 335:256–259. https://doi.org/10.1038/ 335256a0 PMID: 2970594
15. Andrade D, Redecha PB, Vukelic M, Qing X, Perino G, Salom JE, et al. Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease. Arthritis Rheum. 2011; 63(9):2764–2773. https://doi.org/10.1002/art.30424 PMID: 21560114
16. Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishi N, Katano I, et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int Immunol. 2009; 21(7): 843–858. https://doi.org/10.1093/intimm/dxp050 PMID: 19515798
17. Harman BC, Giles-Komar J, Rycyzyn MA. Antibody discovery from immune competent and immune transplanted mice. Curr Drug Discov Technol. 2014; 11(1): 65–73. https://doi.org/10.2174/ 15701638113109990036 PMID: 23978038
18. Zhang T, Pierson RN 3rd, Azimzadeh AM. Update on CD40 and CD154 blockade in transplant models. Immunotherapy 2015; 7(8): 899–911. https://doi.org/10.2217/IMT.15.54 PMID: 26268734
19. Ahmadi T, Files A, Efebera Y, Sherr DH. CD40 Ligand-activated, antigen-specific B cells are compara- ble to mature dendric cells in presenting protein antigens and major histocompatibility complex classⅠ- and class Ⅱ-binding peptides. Immunology. 2008; 124(1): 129–140. https://doi.org/10.1111/j.1365-2567.2007.02749.x PMID: 18067555
20. Lang J, Kelly M, Freed BM, McCarter MD, Kedl RM, Torres RM, et al. Studies of lymphocyte reconstitu- tion in a humanized mouse reveal a requirement of T cells for human B cell maturation. J Immunol 2013; 190(5):2090–2210. https://doi.org/10.4049/jimmunol.1202810 PMID: 23335750
21. Crotty S. A brief history of T cell help to B cells. Nat Rev Immunol. 2015; 15(3): 185–189. https://doi.org/ 10.1038/nri3803 PMID: 25677493
22. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002; 2(7): 465–475. https://doi.org/10.1038/nri844 PMID: 12094221
23. Nojima T, Haniuda K, Moutai T, Matsudaira M, Mizokawa S, Shiratori I, et al. In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nat Commun. 2011; 2: 465. https://doi.org/10.1038/ncomms1475 PMID: 21897376